72 related articles for article (PubMed ID: 15451026)
21. Identification and characterization of a membrane receptor for proteolysis-inducing factor on skeletal muscle.
Todorov PT; Wyke SM; Tisdale MJ
Cancer Res; 2007 Dec; 67(23):11419-27. PubMed ID: 18056470
[TBL] [Abstract][Full Text] [Related]
22. Development of an in-vitro model system to investigate the mechanism of muscle protein catabolism induced by proteolysis-inducing factor.
Gomes-Marcondes MC; Smith HJ; Cooper JC; Tisdale MJ
Br J Cancer; 2002 May; 86(10):1628-33. PubMed ID: 12085214
[TBL] [Abstract][Full Text] [Related]
23. The ubiquitin-proteasome pathway as a therapeutic target for muscle wasting.
Tisdale MJ
J Support Oncol; 2005; 3(3):209-17. PubMed ID: 15915823
[TBL] [Abstract][Full Text] [Related]
24. Downregulation of ubiquitin-dependent protein degradation in murine myotubes during hyperthermia by eicosapentaenoic acid.
Smith HJ; Khal J; Tisdale MJ
Biochem Biophys Res Commun; 2005 Jun; 332(1):83-8. PubMed ID: 15896302
[TBL] [Abstract][Full Text] [Related]
25. The 'cancer cachectic factor'.
Tisdale MJ
Support Care Cancer; 2003 Feb; 11(2):73-8. PubMed ID: 12560934
[TBL] [Abstract][Full Text] [Related]
26. Angiotensin II directly induces muscle protein catabolism through the ubiquitin-proteasome proteolytic pathway and may play a role in cancer cachexia.
Sanders PM; Russell ST; Tisdale MJ
Br J Cancer; 2005 Aug; 93(4):425-34. PubMed ID: 16052213
[TBL] [Abstract][Full Text] [Related]
27. Mechanism of attenuation of angiotensin-II-induced protein degradation by insulin-like growth factor-I (IGF-I).
Russell ST; Eley H; Tisdale MJ
Cell Signal; 2007 Jul; 19(7):1583-95. PubMed ID: 17376652
[TBL] [Abstract][Full Text] [Related]
28. Mechanism of activation of dsRNA-dependent protein kinase (PKR) in muscle atrophy.
Eley HL; Russell ST; Tisdale MJ
Cell Signal; 2010 May; 22(5):783-90. PubMed ID: 20074639
[TBL] [Abstract][Full Text] [Related]
29. Signaling pathways initiated by beta-hydroxy-beta-methylbutyrate to attenuate the depression of protein synthesis in skeletal muscle in response to cachectic stimuli.
Eley HL; Russell ST; Baxter JH; Mukerji P; Tisdale MJ
Am J Physiol Endocrinol Metab; 2007 Oct; 293(4):E923-31. PubMed ID: 17609254
[TBL] [Abstract][Full Text] [Related]
30. In vitro assessment of the combined effect of eicosapentaenoic acid, green tea extract and curcumin C3 on protein loss in C2C12 myotubes.
Mirza KA; Luo M; Pereira S; Voss A; Das T; Tisdale MJ
In Vitro Cell Dev Biol Anim; 2016 Sep; 52(8):838-45. PubMed ID: 27194344
[TBL] [Abstract][Full Text] [Related]
31. Cisplatin triggers atrophy of skeletal C2C12 myotubes via impairment of Akt signalling pathway and subsequent increment activity of proteasome and autophagy systems.
Fanzani A; Zanola A; Rovetta F; Rossi S; Aleo MF
Toxicol Appl Pharmacol; 2011 Feb; 250(3):312-21. PubMed ID: 21074548
[TBL] [Abstract][Full Text] [Related]
32. Downregulation of muscle protein degradation in sepsis by eicosapentaenoic acid (EPA).
Khal J; Tisdale MJ
Biochem Biophys Res Commun; 2008 Oct; 375(2):238-40. PubMed ID: 18703014
[TBL] [Abstract][Full Text] [Related]
33. Effect of a cachectic factor on carbohydrate metabolism and attenuation by eicosapentaenoic acid.
Hussey HJ; Tisdale MJ
Br J Cancer; 1999 Jun; 80(8):1231-5. PubMed ID: 10376976
[TBL] [Abstract][Full Text] [Related]
34. A lipoxygenase metabolite, 12-(S)-HETE, stimulates protein kinase C-mediated release of cathepsin B from malignant cells.
Honn KV; Timár J; Rozhin J; Bazaz R; Sameni M; Ziegler G; Sloane BF
Exp Cell Res; 1994 Sep; 214(1):120-30. PubMed ID: 7521840
[TBL] [Abstract][Full Text] [Related]
35. Leucine suppresses myofibrillar proteolysis by down-regulating ubiquitin-proteasome pathway in chick skeletal muscles.
Nakashima K; Ishida A; Yamazaki M; Abe H
Biochem Biophys Res Commun; 2005 Oct; 336(2):660-6. PubMed ID: 16153608
[TBL] [Abstract][Full Text] [Related]
36. Attenuation of proteasome-induced proteolysis in skeletal muscle by {beta}-hydroxy-{beta}-methylbutyrate in cancer-induced muscle loss.
Smith HJ; Mukerji P; Tisdale MJ
Cancer Res; 2005 Jan; 65(1):277-83. PubMed ID: 15665304
[TBL] [Abstract][Full Text] [Related]
37. Effect of cancer cachexia on the activity of tripeptidyl-peptidase II in skeletal muscle.
Chand A; Wyke SM; Tisdale MJ
Cancer Lett; 2005 Feb; 218(2):215-22. PubMed ID: 15670899
[TBL] [Abstract][Full Text] [Related]
38. Activation of microvascular endothelium by eicosanoid 12(S)-hydroxyeicosatetraenoic acid leads to enhanced tumor cell adhesion via up-regulation of surface expression of alpha v beta 3 integrin: a posttranscriptional, protein kinase C- and cytoskeleton-dependent process.
Tang DG; Diglio CA; Honn KV
Cancer Res; 1994 Feb; 54(4):1119-29. PubMed ID: 8313370
[TBL] [Abstract][Full Text] [Related]
39. The effect of eicosapentaenoic and docosahexaenoic acid on protein synthesis and breakdown in murine C2C12 myotubes.
Kamolrat T; Gray SR
Biochem Biophys Res Commun; 2013 Mar; 432(4):593-8. PubMed ID: 23438435
[TBL] [Abstract][Full Text] [Related]
40. Increased expression of proteasome subunits in skeletal muscle of cancer patients with weight loss.
Khal J; Hine AV; Fearon KC; Dejong CH; Tisdale MJ
Int J Biochem Cell Biol; 2005 Oct; 37(10):2196-206. PubMed ID: 16125116
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
